Related Experiment Video
Updated: Jul 7, 2026
11:42
Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
Published on: July 10, 2017
Platelet interaction with progenitor cells: vascular regeneration or inquiry?
Konstantinos Stellos1, Stephan Gnerlich, Bjoern Kraemer
1Medizinische Klinik III, Eberhard Karls-Universität Tübingen, Otfried-Müller 10, Tübingen, Germany.
Pharmacological Reports : PR
|February 16, 2008
Summary
Stem and progenitor cells aid vascular repair by differentiating into mature cell types. Platelets play a crucial role in guiding these cells to injury sites, influencing vascular regeneration and disease.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Cell Biology
Background:
- Stem and progenitor cells are crucial for vascular repair following tissue ischemia.
- Impaired progenitor cell function or numbers lead to inadequate vascular healing and atherosclerosis.
- Cardiovascular risk factors negatively impact progenitor cell-mediated vascular repair.
Purpose of the Study:
- To investigate the mechanisms of progenitor cell domiciliation and differentiation in peripheral tissues.
- To explore the role of platelets in progenitor cell recruitment and differentiation.
- To understand how platelet interactions influence vascular regeneration and injury.
Main Methods:
- Mobilization, chemotaxis, adhesion, proliferation, and differentiation assays for progenitor cells.
- In vitro and in vivo studies examining platelet-progenitor cell interactions.
- Analysis of progenitor cell differentiation into endothelial cells, macrophages, and foam cells.
Main Results:
- Platelets were found to recruit circulating progenitor cells to sites of vascular injury.
- Adherent platelets induced differentiation of progenitor cells into endothelial cells, macrophages, and foam cells.
- Platelet interaction appears essential for both vascular regeneration and injury processes.
Conclusions:
- Platelets are key mediators in the domiciliation and differentiation of progenitor cells at vascular lesion sites.
- Understanding platelet-progenitor cell interactions is vital for developing therapies for vascular diseases.
- Further research is needed to elucidate the precise mechanisms underlying platelet-driven progenitor cell differentiation.
More Related Videos
Related Concept Videos
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...